Evidence map›Paper›PMID 23900510›Full record

ArticleDiabetologia2013

Nupr1 deletion protects against glucose intolerance by increasing beta cell mass.

Helena C Barbosa-Sampaio, Bo Liu, Robert Drynda, Ana M Rodriguez de Ledesma, Aileen J King, James E Bowe, Cédric Malicet, Juan L Iovanna, Peter M Jones, Shanta J Persaud and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Helena C Barbosa-SampaioDiabetes Research Group, Division of Diabetes and Nutritional Sciences, School of Medicine, King's College London, 2.9N Hodgkin Building, Guy's Campus, London, SE1 1UL, UK.
Bo Liu
Robert Drynda
Ana M Rodriguez de Ledesma
Aileen J King
James E Bowe
Cédric Malicet
Juan L Iovanna
Peter M Jones
Shanta J Persaud
Dany S Muller
King's College London · GBInserm · FR

Funding

Medical Research Council MR/J006742/1
6 · The paper itself

Abstract

aims/hypothesisThe stress-activated nuclear protein transcription regulator 1 (NUPR1) is induced in response to glucose and TNF-α, both of which are elevated in type 2 diabetes, and Nupr1 has been implicated in cell proliferation and apoptosis cascades. We used Nupr1(-/-) mice to study the role of Nupr1 in glucose homeostasis under normal conditions and following maintenance on a high-fat diet (HFD).

methodsGlucose homeostasis in vivo was determined by measuring glucose tolerance, insulin sensitivity and insulin secretion. Islet number, morphology and beta cell area were assessed by immunofluorescence and morphometric analysis, and islet cell proliferation was quantified by analysis of BrdU incorporation. Islet gene expression was measured by gene arrays and quantitative RT-PCR, and gene promoter activities were monitored by measuring luciferase activity.

resultsNupr1(-/-) mice had increased beta cell mass as a consequence of enhanced islet cell proliferation. Nupr1-dependent suppression of beta cell Ccna2 and Tcf19 promoter activities was identified as a mechanism through which Nupr1 may regulate beta cell cycle progression. Nupr1(-/-) mice maintained on a normal diet were mildly insulin resistant, but were normoglycaemic with normal glucose tolerance because of compensatory increases in basal and glucose-induced insulin secretion. Nupr1 deletion was protective against HFD-induced obesity, insulin resistance and glucose intolerance. CONCLUSIONS/

interpretationInhibition of NUPR1 expression or activity has the potential to protect against the metabolic defects associated with obesity and type 2 diabetes.

Indexed as

AnimalsBlotting, WesternDNA-Binding ProteinsFemaleGlucose IntoleranceHumansImmunohistochemistryInsulin-Secreting CellsMaleMiceMice, KnockoutNeoplasm ProteinsDNA-Binding ProteinsNeoplasm ProteinsNupr1 protein, mouse

Identifiers

PMID23900510
OpenAlexW2032139544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.